Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of bazedoxifene plus standard of care in hospitalized COVID-19 pneumonia
2021-000320-35Phase 2Completed
- Sponsor
- Tenax Therapeutics
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bazedoxifene in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by Tenax Therapeutics. Primary endpoint: Safety of bazedoxifene in patients with COVID-19 disease. Started Feb 2021; status: completed.
02
Drugs
bazedoxifene
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on 2021-000320-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000320-35.